Related Experiment Video
Updated: Aug 15, 2025

10:14
Double-stranded RNA Oral Delivery Methods to Induce RNA Interference in Phloem and Plant-sap-feeding Hemipteran Insects
Published on: May 4, 2018
14.0K
Huanglongbing Pandemic: Current Challenges and Emerging Management Strategies
Dilip Ghosh1, Sunil Kokane1, Brajesh Kumar Savita2
1Plant Virology Laboratory, ICAR-Central Citrus Research Institute, Nagpur 440033, India.
Plants (Basel, Switzerland)
|January 8, 2023
Summary
Huanglongbing (HLB) is a devastating citrus disease caused by "Candidatus Liberibacter asiaticus" (CLas). Effective HLB management requires a multi-pronged strategy targeting the pathogen, host, and vector.
Area of Science:
- Plant Pathology
- Bacteriology
- Entomology
Background:
- Huanglongbing (HLB), or citrus greening, is a severe citrus disease threatening the global industry.
- The disease is caused by the phloem-limited bacterium "Candidatus Liberibacter asiaticus" (CLas), transmitted by psyllids.
- Current control measures for HLB are limited, making disease prevention challenging.
Purpose of the Study:
- To provide a comprehensive review of current scientific knowledge on HLB.
- To discuss existing management practices and challenges in controlling CLas.
- To introduce a triangular disease management approach targeting pathogen, host, and vector.
Main Methods:
- Review of scientific literature on HLB and CLas.
- Analysis of pathogen-targeting strategies: inhibiting CLas proteins, using antimicrobials/immunity-inducers, and CLas suppression/killing tools.
- Examination of host-targeting strategies: immune system enhancement, transgenic resistance, and induced systemic acquired resistance.
- Evaluation of vector-targeting strategies: chemical/biological control and tree eradication.
Main Results:
- No single effective long-term commercialized control for HLB currently exists.
- A multi-pronged approach is necessary for effective HLB and CLas management.
- Integrated strategies targeting pathogen, host, and vector show promise.
Conclusions:
- Integrated disease management, incorporating pathogen, host, and vector strategies, is crucial for mitigating the HLB pandemic.
- Further research into novel control methods is essential.
- A hypothetical integrated disease management model is proposed.
Related Concept Videos
Biological Methods for Microbial Control
165
Biological agents offer an effective means of controlling microbial growth by leveraging natural processes like predation, competition, and the secretion of antimicrobial substances.Predatory bacteria such as Bdellovibrio species target and kill pathogens like Salmonella and E. coli. They are widely used in poultry farms to control infections. Myxococcus species help combat plant-pathogenic fungi. These naturally occurring predators serve as eco-friendly alternatives to chemical pesticides and...
165
Pneumonia IV: Management
413
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
413
Chronic Obstructive Pulmonary Disease-V: Management
2.7K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.7K

